“The virus is acting as if its primary target is the endothelium,” he says.
That means the clots are just part of a much larger problem, one Poor says doctors don’t yet know how to solve.
Article: Blood Clots Are Another Dangerous COVID-19 Mystery
Hooman Poor, MD, assistant professor, Department of Pulmonary, Critical Care and Sleep Medicine, Mount Sinai Health System, New York City.
Adam Cuker, MD, associate professor of medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Sharon Fox, MD, PhD, pathologist, Louisiana State University Health, New Orleans.
Mandeep Mehra, MD, medical director, Brigham and Women’s Heart and Vascular Center, Boston.
Intensive Care Medicine: “High risk of thrombosis in patients in severe SARS-CoV-2 infection: a multicenter prospective cohort study.”
The Lancet: “Endothelial cell infection and endotheliitis in COVID-19.”
JAMA: “Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.”